Filing Flows › Harvard Apparatus Regenerative Technology (HRGN) › Q1 2026 › vs Q4 2025
Harvard Apparatus Regenerative Technology (HRGN) Q1 2026 vs Q4 2025 (quarter over quarter)
Harvard Apparatus Regenerative Technology's revenue rose $7K (+3%) from $219K in Q4 2025 to $226K in Q1 2026.
Harvard Apparatus Regenerative Technology, Q1 2026: revenue $226K (+402% year over year), operating margin -710.6%, net loss $1.6M, operating cash flow −$937K. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $226K | $219K | $7K | +3% |
| Other income, net | $5K | $11K | −$6K | -55% |
| Net loss | $1.6M | $1.7M | −$86K | -5% |
| Costs & expenses | $1.8M | $1.9M | −$85K | -4% |
| Operating costs | $1.8M | $1.9M | −$85K | -4% |
| Cost of revenue | $206K | $199K | $7K | +4% |
| Research & development | $563K | $700K | −$137K | -20% |
| General & admin | $1.0M | $986K | $59K | +6% |
| Other operating costs | $18K | $32K | −$14K | -44% |
| Operating cash sources | $1.6M | $1.7M | −$86K | -5% |
| Depreciation | $1K | $1K | $0 | 0% |
| Share-based compensation | $632K | $493K | $139K | +28% |
| Working capital & other | $31K | $529K | −$498K | -94% |
| Cash used in operations | $937K | $664K | $273K | +41% |
| Net loss absorbed | $1.6M | $1.7M | −$86K | -5% |
Questions
How much did Harvard Apparatus Regenerative Technology's revenue grow quarter over quarter in Q1 2026?
Harvard Apparatus Regenerative Technology's revenue rose $7K (+3%) from $219K in Q4 2025 to $226K in Q1 2026.